✦ LIBER ✦

Neurotoxicity associated with deferoxamine therapy

✍ Scribed by Melvin H. Freedman; Marilyn Boyden; Margot Taylor; Barry Skarf

Book ID: 107937575
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 512 KB
Volume: 49
Category: Article
ISSN: 0300-483X
DOI: 10.1016/0300-483x(88)90010-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mucormycosis: association with deferoxam

Mucormycosis: association with deferoxamine therapy

✍ Annemarie L. Daly; Luis A. Velazquez; Suzanne F. Bradley; Carol A. Kauffman 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 480 KB

Serial studies of auditory neurotoxicity

Serial studies of auditory neurotoxicity in patients receiving deferoxamine therapy

✍ C. Schindléry; V. Macarol 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Serial studies of auditory neurotoxicity

Serial studies of auditory neurotoxicity in patients receiving deferoxamine therapy

✍ Tsvi Gallant; Marilyn H. Boyden; Lee Ann Gallant; Holly Carley; Melvin H. Freedm 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 629 KB

Acute neurotoxic effect associated with

Acute neurotoxic effect associated with minocycline therapy

✍ Castot, A.; Garnier, R.; Conso, F.; Efthymiou, M-L. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Combined Therapy with Deferoxamine and D

Combined Therapy with Deferoxamine and Deferiprone

✍ ANTONIS KATTAMIS 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Delayed neurotoxicity associated with th

Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia

✍ Cole, Peter D. ;Kamen, Barton A. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

## Abstract Most children diagnosed today with acute lymphoblastic leukemia (ALL) will be cured. However, treatment entails risk of neurotoxicity, causing deficits in neurocognitive function that can persist in the years after treatment is completed. Many of the components of leukemia therapy can c